ACSL1 and neurodegenerative disease: Conceptually, using an ACSL1 inhibitor to reduce lipid droplets as a treatment for neurodegenerative diseases may be effective; however, its safety profile is a concern, partly because ACSL1 is also responsible for the bulk synthesis of phospholipids, which are essential components of all cell membranes [68].